From Bloomberg News | In a side-by-side test involving 900 British children, Baxter’s Celvapan swine flu vaccine for children was found to produce fewer antibodies than GlaxoSmithKlein’s Pandemrix.
Get the full story: businessweek.com
Baxter loses to Glaxo in UK swine flu test
Posted May 28, 2010 at 7:31 a.m.
